Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line

OBJECTIVES: The objectives of this study were to 1) describe and compare treatment persistence with first- and second-line subcutaneous tumor necrosis factor-alpha inhibitors (SC-TNFis) in patients with ankylosing spondylitis (AS), psoriatic arthritis (PsA), or rheumatoid arthritis (RA) (collectivel...

Descripción completa

Detalles Bibliográficos
Autores principales: Svedbom, Axel, Dalén, Johan, Black, Christopher M, Kachroo, Sumesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248937/
https://www.ncbi.nlm.nih.gov/pubmed/28144130
http://dx.doi.org/10.2147/PPA.S119808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248937/
https://www.ncbi.nlm.nih.gov/pubmed/28144130
http://dx.doi.org/10.2147/PPA.S119808

Ejemplares similares